Mylan launches generic Adderrall

PITTSBURGH — Mylan on Thursday announced the launch of its generic version of Teva’s Adderrall (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate) tablets following approval from the Food and Drug Administration. 

 

The drug will be available in 5-, 7.5-, 10-, 12.5, 15-, 20- and 30-mg tablets and, according to IMS Health, had U.S. sales of about $570.4 million for the 12 months ended Sept. 30.